OR WAIT null SECS
Member of the Executive Committee of Bayer AG’s Pharmaceuticals Division and Head of the Oncology Strategic Business Unit
Scientific advances are benefiting cancer patients, but it will take a pandemic-like response to ensure patients everywhere have access.